BROWN FORMAN (BF-A) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2027, filed Sep 2, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BF-A SEC filings page.
BROWN FORMAN CORP (BF-A) reported $3.9B in revenue over the twelve months to Jul 31, 2026, down 0.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Stable sales are masking weaker operating efficiency, while cash conversion and lower leverage reshape FY2026's financial profile.
Operating cash flow reached$1.0B against net income of$715M , reversing FY2025's weaker cash conversion and showing cash generation materially exceeded accounting profit. That divergence helped free cash flow rise107.2% even as operating income fell9.6% , so FY2026's cash result reflects stronger conversion and lower capital spending rather than operating growth.
Gross margin recovered by
Debt-to-equity fell to 0.5x from 0.6x, giving the business a less debt-dependent capital structure. Current liabilities rose
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of BROWN FORMAN CORP's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
BROWN FORMAN CORP has an operating margin of 25.5%, meaning the company retains $25 of operating profit per $100 of revenue. This strong profitability earns a score of 89/100, reflecting efficient cost management and pricing power. This is down from 27.9% the prior year.
BROWN FORMAN CORP's revenue declined 1.2% year-over-year, from $4.0B to $3.9B. This contraction results in a growth score of 21/100.
BROWN FORMAN CORP has a moderate D/E ratio of 0.52. This balance of debt and equity financing earns a leverage score of 35/100.
With a current ratio of 3.24, BROWN FORMAN CORP holds $3.24 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 81/100.
BROWN FORMAN CORP converts 22.7% of revenue into free cash flow ($893.0M). This strong cash generation earns a score of 81/100.
BROWN FORMAN CORP earns a strong 17.8% return on equity (ROE), meaning it generates $18 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 84/100. This is down from 21.8% the prior year.
BROWN FORMAN CORP scores 4.34, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $13.7B against total liabilities of $3.9B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
BROWN FORMAN CORP passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, BROWN FORMAN CORP generates $1.40 in operating cash flow ($1.0B OCF vs $715.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
BROWN FORMAN CORP earns $9.72 in operating income for every $1 of interest expense ($1.0B vs $103.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
BROWN FORMAN CORP generated $911.0M in revenue in Q1 2027. This represents a decrease of 1.4% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.
BROWN FORMAN CORP's EBITDA was $275.0M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 2.5% from the same quarter a year earlier. Against the prior quarter it is up 129.2%.
BROWN FORMAN CORP reported $176.0M in net income in Q1 2027. This represents an increase of 3.5% from the same quarter a year earlier. Against the prior quarter it is up 225.9%.
BROWN FORMAN CORP earned $0.38 per diluted share (EPS) in Q1 2027. This represents an increase of 5.6% from the same quarter a year earlier. Against the prior quarter it is up 216.7%.
Cash & Balance Sheet
BROWN FORMAN CORP generated $161.0M in free cash flow in Q1 2027, representing cash available after capex. This represents an increase of 24.8% from the same quarter a year earlier. Against the prior quarter it is down 39.2%.
BROWN FORMAN CORP held $301.0M in cash against $2.1B in long-term debt as of Q1 2027.
Not reported for Q1 2027.
Margins & Returns
BROWN FORMAN CORP's gross margin was 60.3% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.3 percentage points.
BROWN FORMAN CORP's operating margin was 27.7% in Q1 2027, reflecting core business profitability. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 17.1 percentage points.
BROWN FORMAN CORP's net profit margin was 19.3% in Q1 2027, showing the share of revenue converted to profit. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 13.4 percentage points.
BROWN FORMAN CORP's quarterly ROE was 4.4% in Q1 2027: one quarter's net income over shareholder equity, not annualized. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.1 percentage points.
Capital Allocation
BROWN FORMAN CORP invested $12.0M in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 61.3% from the same quarter a year earlier. Against the prior quarter it is down 53.8%.
Not reported for Q1 2027.
Not reported for Q1 2027.
BF-A Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $911.0M-1.4% | $912.0M+2.0% | $1.1B+2.0% | $1.0B-5.4% | $924.0M-2.8% | $894.0M-7.3% | $1.0B-3.2% | $1.1B-1.1% |
| Cost of Revenue | $362.0M-2.7% | $341.0M-10.5% | $416.0M0.0% | $421.0M-6.2% | $372.0M-3.6% | $381.0M-3.5% | $416.0M-4.1% | $449.0M+3.0% |
| Gross Profit | $549.0M-0.5% | $571.0M+11.3% | $640.0M+3.4% | $615.0M-4.8% | $552.0M-2.3% | $513.0M-9.8% | $619.0M-2.5% | $646.0M-3.7% |
| SG&A Expenses | $185.0M+4.5% | $259.0M+34.2% | $184.0M+3.4% | $187.0M+1.1% | $177.0M-5.9% | $193.0M-16.5% | $178.0M-12.3% | $185.0M-3.6% |
| Operating Income | $252.0M-3.1% | $96.0M-53.2% | $340.0M+21.4% | $305.0M-10.6% | $260.0M-7.5% | $205.0M-45.3% | $280.0M-24.9% | $341.0M+0.6% |
| EBITDA | $275.0M-2.5% | $120.0M-46.9% | $364.0M+20.5% | $327.0M-9.9% | $282.0M-6.9% | $226.0M-42.9% | $302.0M-24.1% | $363.0M+1.1% |
| Interest Expense | $25.0M0.0% | $26.0M-3.7% | $26.0M-16.1% | $26.0M-18.8% | $25.0M-21.9% | $27.0M-20.6% | $31.0M-6.1% | $32.0M+3.2% |
| Income Tax | $53.0M+6.0% | $17.0M-54.1% | $48.0M-22.6% | $55.0M0.0% | $50.0M-13.8% | $37.0M-54.3% | $62.0M+8.8% | $55.0M-19.1% |
| Net Income | $176.0M+3.5% | $54.0M-63.0% | $267.0M-1.1% | $224.0M-13.2% | $170.0M-12.8% | $146.0M-45.1% | $270.0M-5.3% | $258.0M+6.6% |
| EPS (Basic) | $0.38+5.6% | $0.12-61.3% | $0.58+1.8% | $0.47-14.5% | $0.36-12.2% | $0.31-44.6% | $0.57-5.0% | $0.55+10.0% |
| EPS (Diluted) | $0.38+5.6% | $0.12-61.3% | $0.58+1.8% | $0.47-14.5% | $0.36-12.2% | $0.31-44.6% | $0.57-5.0% | $0.55+10.0% |
| Diluted Shares (Avg) | 460M-2.8% | N/A | 463M-2.1% | 473M-0.1% | 473M0.0% | N/A | 473M-0.6% | 473M-1.5% |
Not reported in any period shown, so not listed: R&D Expenses.
BF-A Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.8B-4.2% | $7.9B-2.4% | $8.3B+2.9% | $8.2B-1.3% | $8.2B-0.4% | $8.1B-1.0% | $8.1B-2.0% | $8.3B+2.7% |
| Current Assets | $4.0B-5.3% | $4.0B-4.9% | $4.2B-1.1% | $4.2B+0.4% | $4.2B+2.4% | $4.2B+3.9% | $4.3B-3.1% | $4.2B-1.8% |
| Cash & Equivalents | $301.0M-36.1% | $308.0M-30.6% | $383.0M-36.1% | $319.0M-23.3% | $471.0M+13.2% | $444.0M-0.4% | $599.0M+1.7% | $416.0M+11.5% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $2.6B-0.5% | $2.5B+1.3% | $2.6B+4.4% | $2.6B-0.2% | $2.6B-0.4% | $2.5B-1.8% | $2.5B-3.1% | $2.6B-0.8% |
| Accounts Receivable | $822.0M-3.0% | $832.0M+0.2% | $983.0M+15.0% | $1.0B+9.2% | $847.0M+5.1% | $830.0M+7.9% | $855.0M-2.6% | $954.0M+0.6% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $1.5B+0.4% | $1.5B+1.1% | $1.5B+7.0% | $1.5B+2.9% | $1.5B+2.9% | $1.5B+3.4% | $1.4B-2.0% | $1.5B+0.5% |
| Total Liabilities | $3.9B-7.8% | $3.9B-5.4% | $4.2B-0.7% | $4.1B-11.7% | $4.2B-11.8% | $4.1B-12.0% | $4.2B-14.9% | $4.6B-0.7% |
| Current Liabilities | $1.2B-19.0% | $1.2B+14.1% | $1.5B+24.7% | $1.4B-8.8% | $1.5B-9.2% | $1.1B-30.7% | $1.2B-23.9% | $1.6B+19.7% |
| Non-Current Liabilities | $2.6B-1.6% | $2.6B-12.3% | $2.7B-11.0% | $2.7B-13.1% | $2.7B-13.1% | $3.0B-2.5% | $3.0B-10.6% | $3.1B-8.6% |
| Long-Term Debt | $2.1B+0.4% | $2.1B-14.0% | $2.1B-11.5% | $2.1B-13.3% | $2.1B-13.0% | $2.4B+2.1% | $2.4B-11.8% | $2.4B-9.9% |
| Total Equity | $4.0B-0.5% | $4.0B+0.7% | $4.1B+6.8% | $4.1B+11.6% | $4.0B+15.1% | $4.0B+13.5% | $3.8B+17.8% | $3.7B+7.3% |
| Retained Earnings | $5.0B+6.3% | $5.0B+6.1% | $5.0B+8.1% | $4.9B+8.5% | $4.7B+9.8% | $4.7B+10.5% | $4.7B+16.9% | $4.5B+15.1% |
BF-A Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $173.0M+8.1% | $291.0M+91.4% | $417.0M+31.5% | $132.0M+17.9% | $160.0M+841.2% | $152.0M-46.7% | $317.0M+19.6% | $112.0M+89.8% |
| Depreciation & Amortization | $23.0M+4.5% | $24.0M+14.3% | $24.0M+9.1% | $22.0M0.0% | $22.0M0.0% | $21.0M0.0% | $22.0M-12.0% | $22.0M+10.0% |
| Stock-Based Compensation | $4.0M0.0% | N/A | N/A | N/A | $4.0M0.0% | N/A | N/A | N/A |
| Capital Expenditures | $12.0M-61.3% | $26.0M-48.0% | $25.0M-44.4% | $25.0M-19.4% | $31.0M-24.4% | $50.0M-37.5% | $45.0M-34.8% | $31.0M+3.3% |
| Free Cash Flow | $161.0M+24.8% | $265.0M+159.8% | $392.0M+44.1% | $107.0M+32.1% | $129.0Mn/m | $102.0M-50.2% | $272.0M+38.8% | $81.0M+179.3% |
| Investing Cash Flow | -$13.0M-750.0% | -$23.0Mn/m | -$25.0M-108.2% | -$25.0Mn/m | $2.0M-80.0% | -$35.0Mn/m | $305.0M+146.0% | -$31.0Mn/m |
| Financing Cash Flow | -$164.0Mn/m | -$337.0Mn/m | -$338.0Mn/m | -$261.0Mn/m | -$138.0Mn/m | -$297.0Mn/m | -$417.0Mn/m | -$78.0Mn/m |
| Dividends Paid | $106.0M-0.9% | $106.0M-0.9% | $107.0M0.0% | $107.0M+3.9% | $107.0M+3.9% | $107.0M+2.9% | $107.0M+3.9% | $103.0M+5.1% |
| Share Buybacks | N/A | $0n/m | $301.0Mn/m | N/A | N/A | $0n/m | $0-100.0% | N/A |
BF-A Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.3%+0.5pp | 62.6%+5.2pp | 60.6%+0.8pp | 59.4%+0.4pp | 59.7%+0.3pp | 57.4%-1.6pp | 59.8%+0.4pp | 59.0%-1.6pp |
| Operating Margin | 27.7%-0.5pp | 10.5%-12.4pp | 32.2%+5.1pp | 29.4%-1.7pp | 28.1%-1.4pp | 22.9%-16.0pp | 27.1%-7.8pp | 31.1%+0.5pp |
| Net Margin | 19.3%+0.9pp | 5.9%-10.4pp | 25.3%-0.8pp | 21.6%-1.9pp | 18.4%-2.1pp | 16.3%-11.3pp | 26.1%-0.6pp | 23.6%+1.7pp |
| Return on Equity | 4.4%+0.2pp | 1.3%-2.3pp | 6.5%-0.5pp | 5.4%-1.5pp | 4.3%-1.4pp | 3.7%-3.9pp | 7.1%-1.7pp | 7.0%-0.1pp |
| Return on Assets | 2.3%+0.2pp | 0.7%-1.1pp | 3.2%-0.1pp | 2.7%-0.4pp | 2.1%-0.3pp | 1.8%-1.4pp | 3.4%-0.1pp | 3.1%+0.1pp |
| Current Ratio | 3.26+0.5x | 3.24-0.6x | 2.77-0.7x | 2.97+0.3x | 2.79+0.3x | 3.88+1.3x | 3.49+0.7x | 2.70-0.6x |
| Debt-to-Equity | 0.520.0x | 0.52-0.1x | 0.51-0.1x | 0.50-0.1x | 0.52-0.2x | 0.61-0.1x | 0.62-0.2x | 0.65-0.1x |
| Liabilities-to-Equity | 0.97-0.1x | 0.96-0.1x | 1.03-0.1x | 0.99-0.3x | 1.05-0.3x | 1.03-0.3x | 1.11-0.4x | 1.25-0.1x |
| Asset Turnover | 0.120.0x | 0.120.0x | 0.130.0x | 0.130.0x | 0.110.0x | 0.110.0x | 0.130.0x | 0.130.0x |
| FCF Margin | 17.7%+3.7pp | 29.1%+17.7pp | 37.1%+10.8pp | 10.3%+2.9pp | 14.0%+16.5pp | 11.4%-9.9pp | 26.3%+7.9pp | 7.4%+4.8pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| BROWN FORMAN CORP BF-A | FY2026 | $3.9B | $715.0M | 18.2% | $13.7B | 65/100 |
| Diageo plc DEO | FY2026 | $27.8B | $2.0B | 7.0% | $52.3B | 49/100 |
| Coca-Cola Consolidated, Inc. COKE | FY2025 | $7.2B | $570.6M | 7.9% | $13.7B | 55/100 |
| Coca-Cola FEMSA, S.A.B DE C.V KOF | FY2025 | $16.2B | $1.3B | 8.2% | $24.5B | 59/100 |
| Constellation Brands, Inc. STZ | FY2026 | $9.1B | $1.7B | 18.5% | $23.4B | 48/100 |
Where BROWN FORMAN CORP Ranks
Frequently Asked Questions
BROWN FORMAN CORP (BF-A) reported $3.9B in total revenue for fiscal year 2026. This represents a -1.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
BROWN FORMAN CORP (BF-A) revenue declined by 1.2% year-over-year, from $4.0B to $3.9B in fiscal year 2026.
Yes, BROWN FORMAN CORP (BF-A) reported a net income of $721.0M over the trailing 12 months to July 31, 2026. In fiscal year 2026 it reported a net income of $715.0M, with a net profit margin of 18.2%.
BROWN FORMAN CORP (BF-A) had EBITDA of $1.1B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2026, BROWN FORMAN CORP (BF-A) had $308.0M in cash and equivalents against $2.1B in long-term debt.
BROWN FORMAN CORP (BF-A) had a gross margin of 60.5% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
BROWN FORMAN CORP (BF-A) had an operating margin of 25.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
BROWN FORMAN CORP (BF-A) had a net profit margin of 18.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Yes, BROWN FORMAN CORP (BF-A) paid $0.92 per share in dividends during fiscal year 2026.
BROWN FORMAN CORP (BF-A) has a return on equity of 17.8% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
BROWN FORMAN CORP (BF-A) generated $893.0M in free cash flow during fiscal year 2026. This represents a 107.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
BROWN FORMAN CORP (BF-A) generated $1.0B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
BROWN FORMAN CORP (BF-A) had $7.9B in total assets as of fiscal year 2026, including both current and long-term assets.
BROWN FORMAN CORP (BF-A) invested $107.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
BROWN FORMAN CORP (BF-A) had a current ratio of 3.24 as of fiscal year 2026, which is generally considered healthy.
BROWN FORMAN CORP (BF-A) had a debt-to-equity ratio of 0.52 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
BROWN FORMAN CORP (BF-A) had a liabilities-to-equity ratio of 0.96 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
BROWN FORMAN CORP (BF-A) had a return on assets of 9.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
BROWN FORMAN CORP (BF-A) trades at 19.0x earnings, its market capitalization divided by $721.0M net income, trailing 12 months to July 31, 2026. The market capitalization is $13.7B as of Nov 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
BROWN FORMAN CORP (BF-A) trades at 3.5x sales, its market capitalization divided by $3.9B revenue, trailing 12 months to July 31, 2026. The market capitalization is $13.7B as of Nov 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
BROWN FORMAN CORP (BF-A) has an Altman Z-Score of 4.34, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
BROWN FORMAN CORP (BF-A) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
BROWN FORMAN CORP (BF-A) has an earnings quality ratio of 1.40x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
BROWN FORMAN CORP (BF-A) has an interest coverage ratio of 9.72x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
BROWN FORMAN CORP (BF-A) scores 65 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.